T2 Biosystems Inc. (TTOO)
0.12
0.01 (8.99%)
At close: Mar 31, 2025, 9:48 AM
T2 Biosystems Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 15.69M | 10.33M | 22.25M | 16.79M | 11.03M | 50.8M | 41.8M | 73.49M | 73.66M | 73.85M | 30.2M | 9.71M |
Short-Term Investments | n/a | n/a | 10M | 25.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 1.65M | 1.55M | 10M | n/a | n/a | 260K | 260K | 260K | n/a | n/a | n/a |
Other Long-Term Assets | 555K | 43K | 153K | 687K | 386K | 386K | 268K | 281K | 459K | 427K | 374K | 387K |
Receivables | 1.42M | 2.16M | 5.13M | 5.1M | 2.83M | 1.79M | 467K | 327K | 369K | 201K | n/a | n/a |
Inventory | 4.82M | 4.35M | 3.91M | 3.64M | 3.6M | 2.68M | 1.34M | 803K | 683K | 115K | n/a | n/a |
Other Current Assets | 3.26M | 2.58M | 3.11M | 2.66M | 2.88M | 2.68M | 1.42M | 1.64M | 1.7M | 1.16M | 195K | 140K |
Total Current Assets | 25.19M | 19.42M | 44.39M | 53.58M | 18.89M | 56.61M | 44.32M | 75.44M | 75.57M | 75.32M | 30.39M | 9.85M |
Property-Plant & Equipment | 9.05M | 13.27M | 14.44M | 14.8M | 9.21M | 7.32M | 10.02M | 13.59M | 10.65M | 2.76M | 1.12M | 1.2M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.61M | 14.97M | 16.14M | 25.49M | 9.59M | 7.7M | 10.54M | 14.13M | 11.37M | 3.5M | 1.49M | 1.58M |
Total Assets | 34.8M | 34.39M | 60.54M | 79.08M | 28.49M | 64.31M | 54.86M | 89.57M | 86.95M | 78.82M | 31.89M | 11.43M |
Account Payables | 1.53M | 1.3M | 2.83M | 2.06M | 3.75M | 744K | 648K | 962K | 1.23M | 735K | 943K | 571K |
Deferred Revenue | 224K | 172K | 518K | 230K | 285K | 697K | 1.74M | 2.44M | 2.15M | 80K | n/a | n/a |
Short-Term Debt | 42.9M | 2.7M | 1.17M | 1.15M | 44.88M | 42.64M | 40.7M | 1.57M | 4.74M | 695K | 1.76M | 820K |
Other Current Liabilities | 11.5M | 5.96M | 7.16M | 6.36M | 11.65M | 8.21M | 8.7M | 7.34M | 5.91M | 4.06M | 1.34M | 738K |
Total Current Liabilities | 56.15M | 10.51M | 11.69M | 9.8M | 60.57M | 52.3M | 51.78M | 9.88M | 12.28M | 4.86M | 4.05M | 2.13M |
Long-Term Debt | 6.6M | 57.87M | 57.15M | 55.77M | 1.87M | 492K | 1.74M | 40.3M | 27.3M | 20.66M | 3.3M | 5.06M |
Other Long-Term Liabilities | n/a | 5.94M | 4.58M | 4.36M | n/a | n/a | n/a | 49K | 436K | 301K | 114.08M | 66.9M |
Total Long-Term Liabilities | 6.68M | 63.85M | 61.75M | 60.55M | 1.92M | 625K | 1.74M | 40.34M | 27.73M | 20.96M | 117.38M | 71.96M |
Total Liabilities | 62.83M | 74.36M | 73.44M | 70.35M | 62.49M | 52.92M | 53.52M | 50.23M | 40.01M | 25.82M | 121.43M | 74.09M |
Total Debt | 49.5M | 59.22M | 57.15M | 55.77M | 44.77M | 43.13M | 42.68M | 41.87M | 32.04M | 20.95M | 5.06M | 5.88M |
Common Stock | 4K | 8K | 166K | 147K | 49K | 44K | 36K | 30K | 24K | 20K | 1K | 1K |
Retained Earnings | -584.3M | -534.53M | -472.22M | -422.98M | -376.18M | -317.17M | -266.12M | -203.69M | -148.88M | -103.59M | -89.54M | -62.66M |
Comprehensive Income | n/a | n/a | -4K | 9K | 0.00 | -11.31M | -9.12M | -7.07M | -4.81M | -3.34M | -2.65M | -2.08M |
Shareholders Equity | -28.04M | -39.97M | -12.9M | 8.73M | -34.01M | 11.39M | 1.34M | 39.34M | 46.94M | 53M | -89.54M | -62.66M |
Total Investments | 651K | 1.65M | 10M | 35.4M | n/a | n/a | 260K | 260K | 260K | n/a | n/a | n/a |